Junhe Li

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial

Howard A. Burris, Takuji Okusaka, Arndt Vogel et al. · The Lancet Oncology · 2024 · 115 citations

Patient-reported Outcomes, Gastrointestinal Oncology, Medicine +7

Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro

Jun Deng, Lei Wan, Jian-Chun Fu et al. · Biochemical and Biophysical Research Communications · 2013 · 107 citations

Mir-21 Enhances, Medicine, Colorectal Cancer +8

miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3

Zhengrong Li, Yi Cao, Zhigang Jie et al. · Cancer Letters · 2012 · 104 citations

Mir-551a Inhibit, Tumor Biology, Medicine +8

Ruscogenin induces ferroptosis in pancreatic cancer cells

Zhiwang Song, Xiaojun Xiang, Junhe Li et al. · Oncology Reports · 2019 · 91 citations · Full text

Tumor Biology, Oncology, Chemoprevention Strategy +15

The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma.

Fang Wu, Junhe Li, Changchen Jang et al. · PubMed · 2014 · 85 citations · Full text

Pathology, Cancer Biology, Tumor Biology +18